Clinical Trial Update: Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the Niacin ER/Lovastatin combination on peak walking time and claudication onset time in patients with intermittent claudicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Vascular Disease

Drugs mentioned

• Lovastatin (Lovastatin)
• Niacin ER (niacin extended-release)

Snippet

Sponsor: Kos Pharmaceuticals | Conditions: Intermittent Claudication, Peripheral Vascular Disease | Phase 3 | Status: COMPLETED